메뉴 건너뛰기




Volumn 4, Issue , 2012, Pages 19-27

Impact of the new clinical breaking points proposed by the clinical and laboratory standards institute (CLSI) in the antifungal susceptibility profile of clinical strains isolated from invasive bloodstream Candida spp. infections in Spain

Author keywords

Antifungal therapy; Bloodstream invasive infections; Candida; Clinical breakpoints; Echinocandin; Epidemiological cut off; Geographical distribution

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

EID: 84857846396     PISSN: 1179559X     EISSN: 1179559X     Source Type: Journal    
DOI: 10.4137/CMT.S8293     Document Type: Article
Times cited : (3)

References (39)
  • 1
    • 34347360557 scopus 로고    scopus 로고
    • Incidente, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals
    • Bassetti M, Treacarichi EM, Righi E, et al. Incidente, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diag Micr infec Dis. 2007;58:325-31.
    • (2007) Diag Micr Infec Dis , vol.58 , pp. 325-331
    • Bassetti, M.1    Treacarichi, E.M.2    Righi, E.3
  • 2
    • 0029075535 scopus 로고
    • Epidemiology of nocosomial fungal infection, with emphasis on Candida species
    • Jarvis WR. Epidemiology of nocosomial fungal infection, with emphasis on Candida species. Clin Infect Dis. 1995;20:1526-30.
    • (1995) Clin Infect Dis , vol.20 , pp. 1526-1530
    • Jarvis, W.R.1
  • 3
    • 20144388435 scopus 로고    scopus 로고
    • Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
    • Almirante B, Rodríguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43:1829-35.
    • (2005) J Clin Microbiol , vol.43 , pp. 1829-1835
    • Almirante, B.1    Rodríguez, D.2    Park, B.J.3
  • 4
    • 0036708351 scopus 로고    scopus 로고
    • Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland
    • Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol. 2002;40:3489-92.
    • (2002) J Clin Microbiol , vol.40 , pp. 3489-3492
    • Asmundsdottir, L.R.1    Erlendsdottir, H.2    Gottfredsson, M.3
  • 5
    • 0032790231 scopus 로고    scopus 로고
    • High rate of non-albicans candidemia in Brazilian tertiary care hospitals
    • Colombo AL, Nucci M, Salomao R, et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis. 1999;34:281-6.
    • (1999) Diagn Microbiol Infect Dis , vol.34 , pp. 281-286
    • Colombo, A.L.1    Nucci, M.2    Salomao, R.3
  • 6
    • 0033829201 scopus 로고    scopus 로고
    • Nosocomial candidemia in nonneutropenic patients at an Italian tertiary care hospital
    • Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in nonneutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis. 2000;19:602-7.
    • (2000) Eur J Clin Microbiol Infect Dis , vol.19 , pp. 602-607
    • Luzzati, R.1    Amalfitano, G.2    Lazzarini, L.3
  • 7
    • 10744222717 scopus 로고    scopus 로고
    • Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000
    • Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38:311-20.
    • (2004) Clin Infect Dis , vol.38 , pp. 311-320
    • Marchetti, O.1    Bille, J.2    Fluckiger, U.3
  • 8
    • 78049500483 scopus 로고    scopus 로고
    • Nationwide sentinel surveillance of bloodstream candida infections in 40 tertiary care hospitals in Spain
    • Cisterna R, Ezpeleta E, Telleria O. Nationwide sentinel surveillance of bloodstream candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol. 2010;48:4200-6.
    • (2010) J Clin Microbiol , vol.48 , pp. 4200-4206
    • Cisterna, R.1    Ezpeleta, E.2    Telleria, O.3
  • 9
    • 0033829201 scopus 로고    scopus 로고
    • Nosocomial candidemia in nonneutropenic patients at an Italian Tertiary care hospital
    • Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in nonneutropenic patients at an Italian Tertiary care hospital. J Clin Microbiol Infect Dis. 2000;19:602-7.
    • (2000) J Clin Microbiol Infect Dis , vol.19 , pp. 602-607
    • Luzzati, R.1    Amalfitano, G.2    Lazzarini, L.3
  • 10
    • 79955605427 scopus 로고    scopus 로고
    • Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: Results from the FUNGEMYCA study
    • Pemán J, Cantón E, Miñana JJ, et al. Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study. Rev Iberoam Micol. 2011;28:91-9.
    • (2011) Rev Iberoam Micol , vol.28 , pp. 91-99
    • Pemán, J.1    Cantón, E.2    Miñana, J.J.3
  • 11
    • 0009080964 scopus 로고    scopus 로고
    • The diagnostic value of fungal surveillance cultures in critically ill patients
    • Pelz RK, Lipsett PA, Swoboda SM, et al. The diagnostic value of fungal surveillance cultures in critically ill patients. Surgical infections. 2000;1: 273-81.
    • (2000) Surgical Infections , vol.1 , pp. 273-281
    • Pelz, R.K.1    Lipsett, P.A.2    Swoboda, S.M.3
  • 12
    • 0242659142 scopus 로고    scopus 로고
    • Attributable mortality of nosocomial candidemia, revisited
    • Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172-7.
    • (2003) Clin Infect Dis , vol.37 , pp. 1172-1177
    • Gudlaugsson, O.1    Gillespie, S.2    Lee, K.3
  • 14
    • 0029058365 scopus 로고
    • Nosocomial bloodstreams infection. Secular trends in rates, mortality, and contribution to total hospital deaths
    • Pittet D, Wenzel RP. Nosocomial bloodstreams infection. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177-84.
    • (1995) Arch Intern Med , vol.155 , pp. 1177-1184
    • Pittet, D.1    Wenzel, R.P.2
  • 15
    • 0345340404 scopus 로고    scopus 로고
    • The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
    • Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996;100:617-23.
    • (1996) Am J Med , vol.100 , pp. 617-623
    • Nguyen, M.H.1    Peacock, J.E.2    Morris, A.J.3
  • 16
    • 33644506461 scopus 로고    scopus 로고
    • Epidemiological trends in nosocomial candidemia in intensive care
    • Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BCM Infect Dis. 2006;10:21.
    • (2006) BCM Infect Dis , vol.10 , pp. 21
    • Bassetti, M.1    Righi, E.2    Costa, A.3
  • 17
    • 0036720774 scopus 로고    scopus 로고
    • Secular trend of hospital-acquired candidemia among intensive care unit patients in the united States during 1989-99
    • Trick WE, Fridkin SK, Edwards JR, et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the united States during 1989-99. Clin Infect Dis. 2002;35:627-30.
    • (2002) Clin Infect Dis , vol.35 , pp. 627-630
    • Trick, W.E.1    Fridkin, S.K.2    Edwards, J.R.3
  • 18
    • 17144466471 scopus 로고
    • Secular trends in nosocomial primary bloodstream infections in the United States
    • Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States. Am J Med. 1991;91: 86-9.
    • (1991) Am J Med , vol.91 , pp. 86-89
    • Banerjee, S.N.1    Emori, T.G.2    Culver, D.H.3
  • 19
    • 0027511893 scopus 로고
    • Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-90
    • Beck-Sague CM, Jarvis W. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-90. J Infect Dis. 1993;167: 1247-51.
    • (1993) J Infect Dis , vol.167 , pp. 1247-1251
    • Beck-Sague, C.M.1    Jarvis, W.2
  • 20
    • 10744222717 scopus 로고    scopus 로고
    • Epidemiology of candidemia in swiss teriary care hospitals: Secular trends, 1991-2000
    • Marchetti O, Billie J, Fluckiger U, et al. Epidemiology of candidemia in swiss teriary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38: 311-20.
    • (2004) Clin Infect Dis , vol.38 , pp. 311-320
    • Marchetti, O.1    Billie, J.2    Fluckiger, U.3
  • 21
    • 0034834774 scopus 로고    scopus 로고
    • International surveillance of bloodstream infection due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program
    • Pfaller MA, Diekema DJ, Jones RN, et al. International surveillance of bloodstream infection due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol. 2001;39:3254-9.
    • (2001) J Clin Microbiol , vol.39 , pp. 3254-3259
    • Pfaller, M.A.1    Diekema, D.J.2    Jones, R.N.3
  • 22
    • 50949116280 scopus 로고    scopus 로고
    • Association of fluconazole pharmacodynamics with mortality in patients with candidemia
    • Baddley JW, Patel M, Bhavnani SM, et al. association of fluconazole pharmacodynamics with mortality in patients with candidemia. Antimicrob Agents Chemother. 2008;52:3022-8.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3022-3028
    • Baddley, J.W.1    Patel, M.2    Bhavnani, S.M.3
  • 24
    • 0026534498 scopus 로고
    • In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B
    • Dermoumi H. In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B. Chemotherapy. 1992;38:112-7.
    • (1992) Chemotherapy , vol.38 , pp. 112-117
    • Dermoumi, H.1
  • 25
    • 0024418245 scopus 로고
    • Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei
    • Fisher MA, Shen SH, Haddad J, Tarry WF. Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother. 1989;33: 1443-6.
    • (1989) Antimicrob Agents Chemother , vol.33 , pp. 1443-1446
    • Fisher, M.A.1    Shen, S.H.2    Haddad, J.3    Tarry, W.F.4
  • 26
    • 0034075720 scopus 로고    scopus 로고
    • Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750
    • Barchiesi F, Calabrese D, Sanglard D. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother. 2000;44:1578-84.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 1578-1584
    • Barchiesi, F.1    Calabrese, D.2    Sanglard, D.3
  • 28
    • 79953214056 scopus 로고    scopus 로고
    • In vitro activity of echinocandins against noncandida albicans: Is echinocandin antifungal activity the same?
    • Espinel-Ingroff A, Canton E. In vitro activity of echinocandins against noncandida albicans: is echinocandin antifungal activity the same? Enferm Infec Microbiol Clin. 2011;29:3-9.
    • (2011) Enferm Infec Microbiol Clin , vol.29 , pp. 3-9
    • Espinel-Ingroff, A.1    Canton, E.2
  • 29
    • 53149145998 scopus 로고    scopus 로고
    • Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: Analysis and proposal for interpretive MIC breakpoints
    • Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol. 2008;46:2620-9.
    • (2008) J Clin Microbiol , vol.46 , pp. 2620-2629
    • Pfaller, M.A.1    Diekema, D.J.2    Ostrosky-Zeichner, L.3
  • 31
    • 0037137576 scopus 로고    scopus 로고
    • Comparison of caspofungin and amphotericin B for invasive candidiasis
    • Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med. 2002;347:2020-9.
    • (2002) N Engl J Med , vol.347 , pp. 2020-2029
    • Mora-Duarte, J.1    Betts, R.2    Rotstein, C.3
  • 32
    • 27744463412 scopus 로고    scopus 로고
    • Anidulafungin: A new echinocandin with a novel profile
    • Vazquez JA. Anidulafungin: a new echinocandin with a novel profile. Clin Ther. 2005;27:657-73.
    • (2005) Clin Ther , vol.27 , pp. 657-673
    • Vazquez, J.A.1
  • 33
    • 23844465659 scopus 로고    scopus 로고
    • Echinocandins: Role in antifungal therapy, 2005
    • Zaas AK, Alexander BD. Echinocandins: role in antifungal therapy, 2005. Exp Opin Pharmacother. 2005;6:1657-68.
    • (2005) Exp Opin Pharmacother , vol.6 , pp. 1657-1668
    • Zaas, A.K.1    Alexander, B.D.2
  • 34
    • 79959193758 scopus 로고    scopus 로고
    • Clinical breakpoints for voriconazole and Candida spp. revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
    • Pfaller MA, Andes D, Arendrup MC, et al. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis. 2011;70: 330-43.
    • (2011) Diagn Microbiol Infect Dis , vol.70 , pp. 330-343
    • Pfaller, M.A.1    Andes, D.2    Arendrup, M.C.3
  • 35
    • 79952347827 scopus 로고    scopus 로고
    • Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values
    • Pfaller MA, Espinel-Ingroff A, Boyken L, et al. Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values. J Clin Microbiol. 2011; 49:845-50.
    • (2011) J Clin Microbiol , vol.49 , pp. 845-850
    • Pfaller, M.A.1    Espinel-Ingroff, A.2    Boyken, L.3
  • 36
    • 84898693920 scopus 로고    scopus 로고
    • CLSI Antifungal Subcommittee
    • CLSI Antifungal Subcommittee. Current breakpoints and epidemiological cut-off values for molds 2011; http://www.clsi.org/Content/NavigationMenu/Committees/Microbiology/SCAntifungalSusceptibilityTesting/January2010AntifungalSusceptibilityMeetingPresentations/4f_MPfaller_YeastsBPS_MouldsECVs_Table_20110419.pdf.
    • Current Breakpoints and Epidemiological Cut-off Values For Molds 2011
  • 37
    • 84857877569 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, Third Edition, Clinical Laboratory Standards Institute, Wayne, PA
    • Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, Third Edition. Document M27-A3. Clinical Laboratory Standards Institute, Wayne, PA; 2008.
    • (2008) Document M27-A3
  • 38
    • 73949126140 scopus 로고    scopus 로고
    • Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp
    • Pfaller MA, Boyden L, Hollis RJ, et al. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol. 2010;48:52-6.
    • (2010) J Clin Microbiol , vol.48 , pp. 52-56
    • Pfaller, M.A.1    Boyden, L.2    Hollis, R.J.3
  • 39
    • 79955538785 scopus 로고    scopus 로고
    • Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
    • Pfaller MA, Diekema DJ, Andes D, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14:164-76.
    • (2011) Drug Resist Updat , vol.14 , pp. 164-176
    • Pfaller, M.A.1    Diekema, D.J.2    Andes, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.